Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heliox vs nitrogen-oxygen mixture in mechanically ventilated adults with acute lung injury
2007-000053-62Phase 4Unknown
- Sponsor
- Ashford and St Peter's Hospitals NHS Foundation Trust
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of heliox21 in acute lung injury (ALI) and respiratory failure (2 arms), sponsored by Ashford and St Peter's Hospitals NHS Foundation Trust. Primary endpoints: Peak airway pressure with Heliox vs nitrogen-oxygen mixture and Oxygenation with Heliox vs nitrogen-oxygen mixture. Status: unknown.
02
Drugs
heliox21
03
Conditions
acute lung injury (ALI)respiratory failure
Beyond the preview
Go deeper on 2007-000053-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000053-62.